Associated Papers
Are TP53 Arg72Pro and MDM2 T309G polymorphisms associated with bladder cancer risk? A meta-analysis.
Abderrahmane RK et al.
African Health Sciences, 2024
Association between rs3088440 (G > A) polymorphism at 9p21.3 locus with the occurrence and severity of coronary artery disease in an Iranian population.
Pourgholi M et al.
Molecular Biology Reports, 2021
Association of p16 (CDKN2A) polymorphisms with the development of HPV16-related precancerous lesions and cervical cancer in the Greek population.
Tsakogiannis D et al.
Journal of Medical Virology, 2018
Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors.
Kafadar A et al.
Anticancer Research, 2015
Frequency of genetic and epigenetic alterations of p14ARF and p16INK4A in head and neck cancer in a Hungarian population.
Kis A et al.
Pathology Oncology Research : Por, 2014
Association between p16(CDKN2A) C540G polymorphism and tumor behavior in prolactinoma: A single-center study.
Cander S et al.
Biomedical Reports, 2014
Association of CDKN2A polymorphisms with the severity of cervical neoplasia in a Brazilian population.
Vargas-Torres SL et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 2014
Do CDKN2 p16 540 C>G, CDKN2 p16 580 C>T, and MDM2 SNP309 T>G gene variants act on colorectal cancer development or progression?
Tuna G et al.
Dna and Cell Biology, 2013
The impact of pharmacogenetics on radiation therapy outcome in cancer patients. A focus on DNA damage response genes.
Borchiellini D et al.
Cancer Treatment Reviews, 2012
Association analysis of p16 (CDKN2A) and RB1 polymorphisms with susceptibility to cervical cancer in Indian population.
Thakur N et al.
Molecular Biology Reports, 2012
Role of human papillomavirus and cell cycle-related variants in squamous cell carcinoma of the oropharynx.
Li G et al.
Journal of Biomedical Research, 2010
Cell proliferation-related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysis.
Gao L et al.
European Journal of Human Genetics : Ejhg, 2009
Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation.
Chen J et al.
Annals of Surgical Oncology, 2009
The inherited genetic component of sporadic pancreatic adenocarcinoma.
Milne RL et al.
Pancreatology : Official Journal of the International Association of Pancreatology (iap) ... [et Al.], 2009
Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians.
Chen J et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2007
Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract.
Geddert H et al.
Journal of Cancer Research and Clinical Oncology, 2005
Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study.
Zheng Y et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2002
p16(CDKN2) gene polymorphism: association with histologic subtypes of epithelial ovarian cancer in China.
Yan L et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 0
The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage.
Turgut S et al.
In Vivo (athens, Greece), 0